Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$14.32 - $19.88 $2.63 Million - $3.65 Million
183,800 New
183,800 $2.71 Million
Q1 2022

May 11, 2022

SELL
$15.39 - $20.25 $17.6 Million - $23.1 Million
-1,140,700 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$15.91 - $18.72 $13.5 Million - $15.9 Million
847,800 Added 289.45%
1,140,700 $19.9 Million
Q3 2021

Nov 10, 2021

BUY
$13.06 - $17.24 $3.83 Million - $5.05 Million
292,900 New
292,900 $4.89 Million
Q4 2020

Feb 11, 2021

SELL
$9.33 - $12.48 $620,445 - $829,920
-66,500 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$10.33 - $14.49 $61,980 - $86,940
6,000 Added 9.92%
66,500 $695,000
Q2 2020

Aug 13, 2020

BUY
$11.49 - $15.26 $695,145 - $923,230
60,500 New
60,500 $846,000
Q1 2020

May 13, 2020

SELL
$8.11 - $15.23 $1.31 Million - $2.46 Million
-161,300 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$10.28 - $14.38 $191,208 - $267,468
-18,600 Reduced 10.34%
161,300 $2.28 Million
Q3 2019

Nov 08, 2019

BUY
$10.05 - $14.55 $262,305 - $379,755
26,100 Added 16.97%
179,900 $1.9 Million
Q2 2019

Aug 09, 2019

SELL
$13.1 - $14.95 $430,990 - $491,855
-32,900 Reduced 17.62%
153,800 $2.24 Million
Q1 2019

May 15, 2019

BUY
$13.69 - $20.06 $424,390 - $621,860
31,000 Added 19.91%
186,700 $2.62 Million
Q4 2018

Feb 12, 2019

SELL
$13.96 - $18.26 $813,868 - $1.06 Million
-58,300 Reduced 27.24%
155,700 $2.72 Million
Q3 2018

Nov 05, 2018

BUY
$13.63 - $15.7 $2.92 Million - $3.36 Million
214,000 New
214,000 $3.26 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.